Neurofibromatosis and Schwannomatosis Therapeutics Market...

added blog Home

2026-07-30 07:04:38 - Translate

Neurofibromatosis and Schwannomatosis Therapeutics Market Innovation Trends in Rare Disease Care

The global Neurofibromatosis and Schwannomatosis Therapeutics Market is set to experience robust expansion, growing from USD 1.1 billion in 2026 to USD 2.3 billion by 2036 at a Compound Annual Growth Rate (CAGR) of 7.7%. The market entered 2026 up from USD 1.0 billion in 2025, catalyzed by the approval of mirdametinib (GOMEKLI)—the second...

0 Comments 0 Shares 807 Views 0 Reviews